Company news

Seer, Inc. (NASDAQ:SEER) news

Seer, Inc. news releases on 6ix. Latest, Sep 23, 2026: Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K…

Seer, Inc. (NASDAQ:SEER) news

Press releases & updates

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026

Seer Announces CFO Transition

Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale

Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.’s Board of Directors

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers

Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

Seer Stockholders Vote to Re-Elect All Seven of Seer’s Director Nominees at 2026 Annual Meeting

Radoff-JEC Group Urges Seer Stockholders to Vote “FOR” All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY

Radoff-JEC Group Urges Seer Stockholders to Vote "FOR" All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY

Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc.

Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY

Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

Radoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc.

Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight

The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of History

Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees

The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.

Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.

The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change

The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today

Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Seer Files Patent Infringement Lawsuit Against Nanomics

Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal

Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

The Radoff-JEC Group Issues Open Letter to Seer Inc.’s Board of Directors Regarding the Immediate Need for Significant Change

Leading Scientists Demonstrate How Seer’s Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026

Seer to Participate in the TD Cowen 46th Annual Health Care Conference

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025